With Merck’s COVID Antiviral Announcement, Can the Pharma Pipeline Build Treatment Momentum?

 

At the start of the month, pharmaceutical company Merck dropped big news: It has developed a COVID antiviral drug that would cut hospitalization and mortality risks by 50%. In the drug’s study, patients taking the placebo pill saw 14% hospitalization rate and eight deaths, while the trial group with Merck’s drug had only 7% hospitalized and zero deaths.

This appears to be just the tip of the iceberg; Kaiser Health News reports at least three COVID antiviral candidates, including Merck’s, going through late-stage clinical trials, meaning a variety of COVID drugs could be on patient’s prescriptions here soon. What’ll be some of the positive domino effects to come from approval of COVID antivirals, not only on the pharmaceutical production pipeline, but on the general population’s health? Ira Leiderman, managing director of the healthcare practice at Cassel Salpeter & Co., gave MarketScale his take on the coming treatments.

Follow us on social media for the latest updates in B2B!

Image

Latest

TGR Foundation
Tiger Woods’ TGR Foundation Is Reimagining Educational Access Through STEAM, AI, and Community Partnerships
May 19, 2026

As schools across the United States continue grappling with post-pandemic learning loss, declining student engagement, and shrinking emergency funding, nonprofit organizations are increasingly stepping in to fill critical gaps. Recent national studies on literacy recovery, student engagement, and career-connected learning show that educators are facing significant post-pandemic challenges in keeping students connected to pathways that…

Read More
Talent
Higher Ed Must Build a Talent Supply Chain to Fix Workforce Readiness
May 18, 2026

The traditional pathway from college to career is starting to break down—and both universities and employers are feeling the strain. Higher education is under mounting pressure to prove career outcomes as employers question graduate readiness and internships decline. In fact, many institutions are reporting shrinking internship pipelines even as employers continue to prioritize prior…

Read More
healthcare
The Healthcare Talent Fix: Build Pipelines Early, Use Data, and Get the Experience Right
May 18, 2026

There’s a growing tension inside healthcare right now—between the people leaving the workforce and the patients still arriving every day. It’s a dynamic that leaders can no longer afford to ignore. The numbers make that clear: the Association of American Medical Colleges estimates that the U.S. could be short of as many as 86,000 physicians…

Read More
education
Just Thinking… About Federal Funds, Student Support, and the Future of Education with Eric Reaves
May 15, 2026

As conversations around the future of the U.S. Department of Education continue to intensify, educators and federal program leaders are facing mounting uncertainty about how federal funds will be managed, distributed, and regulated. At the same time, schools serving historically underserved students remain heavily reliant on programs like Title I and other federally supported initiatives…

Read More